by Lawrence Jones, Ph.D. Some of our newest industry interests in the Hopkins Biotech Network (HBN) comes from Johns Hopkins alumni School of Engineering graduates, Baptiste Coudrillier, Ph.D. and Benjamin…
Read More
Mathias (August 10, 2018) reports that Alnylam Pharmaceuticals Inc’s drug for a rare hereditary disease won U.S. regulatory approval on Friday, August 10, 2018. This is newsworthy for the very…
Written by: Jessica Joseph PhD Candidate: Cellular and Molecular Medicine While working towards a Masters or PhD in the biological sciences, it can be difficult to gauge what kinds of…
Company: miRecule Internship title: Company Operations and Business Development Intern This is a great opportunity if you are interested in learning about the business side of a start-up, entrepreneurship, operations…
Details Date: June 21 Time: 2:00 PM – 8:00 PM Event Categories: Entrepreneur, Life Science Website: https://www.eventbrite.com/e/inova-2018-discovery-series-early-stage-investing-in-health-technology-tickets-45749122858
McCue, T.J (May 24, 2018): “Stem cells are the microchips of tomorrow’s tech. They need to be manufactured to quality specifications. As soon as you can buy off the shelf,…
By Nate Hughes Johns Hopkins Alumnus MPH ‘12 As Director of Strategic Partnerships in North America for a bio engineering software firm called Bio-G based in Berkeley, CA, I am writing…
Authored by Veta Obazenu Johns Hopkins Graduate Student Biofilm is a familiar topic in dentistry and internal medicine. The bacteria containing biofilm can be found commonly in the mouth in…
Author: MBA Student and HBN Board Member- Nariman Ziaee On December 1st of 2017, United States Chamber of Commerce hosted its second annual case competition. At this competition, The Chamber…
Author: Alumnus-Lawrence Jones Photo Courtesy: Environmental Biotechnology Kück and Dinkel (2015) posit that biotechnology has a broad reach and thus there must exist color coded classifications to provide a categorical…
